The European Commission approved on Friday the proposed merger of US drug manufacturers Pfizer and Wyeth, subject to Pfizer renouncing some of its animal health products in Europe.
Pfizer, already the world’s biggest pharmaceutical firm, announced the planned merger in January, seeking diversification as it prepares for the expiration of patents on its blockbuster drugs.
The US$68 billion deal appears to be the biggest takeover in the global pharmaceutical sector since Pfizer acquired Warner-Lambert Co for US$93.4 billion in 2000, financial analysts say.
COMMITMENT
The EU’s executive branch, which enforces EU competition law, said the merger was conditional on “Pfizer’s commitment to divest several types of animal health vaccines, pharmaceuticals and medicinal feed additives” in Europe.
“The commission had concerns that the transaction, as originally notified, would have raised competition issues in the field of animal health products on a number of national markets,” it said in a statement.
“In the light of the commitments offered by Pfizer, the Commission has now concluded that the proposed transaction would not significantly impede effective competition in the EEA or any substantial part of it.”
The European Economic Area (EEA) includes the 27 EU member states plus Iceland, Liechtenstein and Norway.
DIVESTMENT
In addition, the European Commission said Pfizer — best known for the anti-cholesterol treatment Lipitor and erectile dysfunction drug Viagra, as well as AIDS drugs — has offered to “divest” a Wyeth plant in Sligo, Ireland.
“In the area of human health, the companies’ activities are to a large extent complementary,” it said.
The merger still awaits a green light from competition authorities in the US, China and other jurisdictions, as well as approval from Wyeth shareholders, a statement on Pfizer’s Web site said.
If the deal goes ahead, the combined company will be No. 1 in terms of biopharmaceutical revenues in the US with a market share of about 12 percent. It will hold about 10 percent of the market in Europe.
Federal Reserve Bank of Philadelphia President Anna Paulson on Thursday joined the chorus of policymakers saying additional interest-rate increases may be needed to ensure inflation returns to the central bank’s 2 percent goal. “Looking ahead, if conditions evolve as I expect, some modest further tightening may be warranted,” Paulson said on Thursday at an event in Philadelphia. Earlier on Thursday, New York Fed President John Williams said he and his colleagues “still have a lot of work to do” in dealing with lingering inflation risks. Several other officials have aired similar comments, in line with the signal given last week when policymakers voted
COURSE CHANGE: The shift comes amid pressure from chipmakers for stable, low-carbon electricity. Officials said Ma-anshan could be restarted as early as 2028 Taiwan has approved a preliminary plan to restart an idled atomic power plant, marking a reversal of the ruling party’s anti-nuclear stance as the nation pursues greater energy security. The Nuclear Safety Commission has cleared its review of an initial proposal to restart the Ma-anshan Nuclear Power Plant, it said in a statement on Thursday. Taiwan Power Co (台電) will still need to carry out follow-up work including safety inspections, before submitting another report on implementation for review, the commission said. The earliest the plant could resume operations is 2028, according to previous reports in local media, citing Minister of Economic Affairs
MINIMAL EXPECTATIONS: Analysts think that the two sides are likely to aim for ‘status quo’-level agreements, maintaining civility, without major trade breakthroughs US Secretary of the Treasury Scott Bessent and Chinese Vice Premier He Lifeng (何立峰) were set to meet yesterday to try to set up potential agreements on artificial intelligence (AI), tariffs and critical minerals for a summit in Washington this week between US President Donald Trump and Chinese President Xi Jinping (習近平). The meetings at JPMorgan Chase & Co’s headquarters in Manhattan, which included US Trade Representative Jamieson Greer, were due to start at about 10:30am on Sunday morning and were expected to run all day. Key topics would be the status of a US-China trade truce that is set to expire
GlobalFoundries Inc yesterday said it plans to accelerate global capacity optimization and expansion to accommodate exponential growth in radio frequency (RF) and other chips driven by the artificial intelligence (AI) boom. Singapore will pay a vital role in the company’s capacity expansion, alongside production line optimizations across its manufacturing sites, GlobalFoundries Asia Pacific head Vincent Feng (范曾文) told a news conference in Hsinchu City. “Many might be surprised to hear that the RF market is thriving now. We are gearing up for a massive capacity expansion, and it is all being driven by AI,” Feng said. He declined to disclose details of the
RSS